Diagnosing cerebral palsy isn’t a single test: it’s a coordinated set of assessments that together build the clinical picture. Knowing what each test measures, when it’s used, and how the pieces connect helps families understand what’s happening as a workup unfolds.
Parents working through a cerebral palsy workup often see a long list of recommended tests and wonder how they connect. The truth is that no single test diagnoses CP: the clinical picture comes together from many sources: the developmental history, the neurological exam, standardized assessments, brain imaging, and sometimes genetic testing. This guide is a field guide to the full toolkit: what each test measures, when it’s used, and how the pieces fit together.
For the umbrella view of how cerebral palsy is diagnosed, see the parent guide. For the structured criteria that define a CP diagnosis, see cerebral palsy diagnostic criteria. This page focuses specifically on the tests themselves, what each one does and how it contributes.
Catching CP early starts with consistent surveillance: well-child visits, standardized screening, and parental observation. The earliest indicators are subtle, but they cluster in recognizable patterns that experienced clinicians can identify.
The detection process is layered. Pediatricians monitor development at routine visits, parents observe behavior at home, and standardized tools systematize what would otherwise be subjective impression. When concerns cluster across these layers, formal evaluation begins.
Certain patterns prompt screening or referral.
Seven findings prompt closer screening. Abnormal muscle tone in either direction, floppy or stiff, usually noticed by a parent during ordinary handling. Primitive reflexes that outstay their window, with the Moro reflex normally gone by six months and the palmar grasp by five or six. Asymmetric movement, including a strong hand preference before age one, which is a red flag rather than early talent. Missed motor milestones: not rolling by six months, not sitting by nine, not pulling to stand by twelve. Fists still clenched past four or five months. Feeding difficulty, meaning poor sucking, choking or persistent drooling beyond infancy. And unusual posture such as arching, scissoring legs, or head lag when pulled to sitting.
For a fuller walkthrough of what to watch for in the first year, see our deeper guide on early signs of cerebral palsy in infants.
Milestones give the structured framework for tracking development.
The milestones used as checkpoints are specific: steady head control and reaching for toys by three to four months; rolling both directions with hands to midline by four to six; sitting unsupported and transferring objects between hands by six to nine; pulling to stand, cruising and beginning to walk by nine to twelve; and walking independently while using both hands together by twelve to eighteen months.
Milestone delays alone don’t diagnose CP, but they’re the most common entry point into the workup. A child consistently delayed across multiple motor milestones (especially with the qualitative concerns above) is the typical referral profile.
Screening combines hands-on motor assessment with imaging when concerns arise. Each method answers a different question, and the right combination depends on the child’s age, history, and presenting concerns.
Screening is broader than testing for CP specifically: it’s structured developmental surveillance that catches a range of concerns. The tools below are the ones most relevant when CP is on the differential.
Several standardized assessments are in routine use.
Six standardized tools do the assessment work. The General Movements Assessment observes spontaneous movement in infants up to five months and is the most predictive single tool available, with a sensitivity around 98%. The Hammersmith Infant Neurological Examination is a structured exam for infants from two to 24 months, scoring cranial nerve function and posture, and reaches around 90%. The Bayley Scales track cognitive, motor and language development in early-intervention programmes. The Peabody Developmental Motor Scales measure fine and gross motor skills from birth to five years. The Ages and Stages Questionnaire is parent-completed and used at well-child visits. And the Gross Motor Function Measure tracks change over time once a diagnosis is established.
The GMA and HINE are the two most CP-specific tools. They’re used routinely in major neurodevelopmental follow-up clinics and increasingly in community settings.
Imaging confirms what clinical assessment suggests, and each modality has its own uses.
Four imaging tools cover the rest. Brain MRI is the reference standard, showing the type and location of injury or malformation, and it is abnormal in roughly 86% of children with cerebral palsy. Cranial ultrasound is the NICU workhorse, usable while the fontanelle is open until around 12 to 18 months, good at hemorrhage and poor at subtle white matter change. CT is faster but delivers ionizing radiation, so it is reserved for emergencies and for settings without MRI. And EEG records electrical activity rather than structure, diagnosing epilepsy rather than cerebral palsy, which matters because roughly 4 in 10 children with cerebral palsy have both.
For a fuller look at how MRI specifically contributes to CP diagnosis, see our dedicated guide on the role of MRI in cerebral palsy diagnosis.
A typical screening evaluation combines several elements.
A screening appointment typically covers a detailed parental questionnaire about milestones, a structured motor and neurological exam, standardized scoring using the Hammersmith, Bayley or a similar tool, observation of the child during play, and a recommendation about follow-up imaging or specialist referral.
When initial screening identifies concerns, more specific diagnostic tests confirm the picture. Diagnostic tests aren’t fundamentally different from screening tools. They’re often the same tools used at greater depth, plus additional modalities like genetic testing and physical therapy evaluation.
The line between screening and diagnostic isn’t always sharp. A pediatrician’s ASQ at a well-child visit is a screening tool; a pediatric neurologist’s HINE done after a referral is a diagnostic tool, even though both can use similar standardized scales. What matters is the depth, the expertise of the clinician, and whether the goal is to detect concerns (screening) or characterize what’s happening (diagnostic).
Genetic testing has moved from research curiosity to a clinical option in many cases.
Genetic testing enters in four situations. When the MRI is normal, which happens in roughly 15% of cases and where genetic causes are the most common explanation. When the presentation is atypical, with movement patterns that do not fit. When family history suggests a genetic component. And when ruling out the look-alikes, since hereditary spastic paraplegia, dopa-responsive dystonia and several metabolic disorders mimic cerebral palsy and, unlike it, are progressive or treatable.
The most common test is whole-exome sequencing (WES), often combined with chromosomal microarray. For when, why, and how genetic testing fits into the diagnostic workup, see our dedicated guide on genetic testing for cerebral palsy.
Physical therapy evaluations contribute functional information nothing else supplies.
A physical therapy evaluation contributes five things: detailed documentation of strength, range of motion, postural control and movement quality; objective standardized scores using tools like the GMFM and Peabody that can track change; identification of secondary problems such as tightness, contracture and compensatory patterns; input that shapes both the therapy and its specific goals; and differential diagnosis support, since particular motor patterns separate cerebral palsy from cerebellar disorders and neuromuscular disease.
PT evaluations typically happen alongside the medical workup rather than after diagnosis is finalized. Most children with motor concerns are referred to PT before the diagnostic picture is fully clear, therapy doesn’t need to wait for confirmation. For more on how PT fits into ongoing care, see physical therapy for cerebral palsy.
Screening matters because it’s the gatekeeper to early intervention. Catching concerns early opens access to therapy, supports, and resources during the developmental window when they have the biggest impact.
The case for routine screening is straightforward: brain plasticity is highest in the first three years, therapy works best during that window, and early-intervention services are most accessible when concerns are identified during infancy. Every layer of screening (well-child visits, parental observation, standardized tools, specialist evaluation) raises the chances that concerns reach a clinician’s attention while there’s still time to act.
What therapy accomplishes when started early is measurable.
Starting early produces measurably different outcomes. Children who begin physical therapy as infants achieve better gross motor function than those starting later. Early occupational therapy builds the foundations for feeding, dressing and self-care. Speech therapy begun in infancy supports oral motor coordination and feeding as well as language. Early tone management prevents the contractures, hip displacement and postural deformity that are far harder to reverse than to avoid. And the same neuroplasticity that supports motor learning supports cognitive and social development, which is why the first three years matter so much.
For a deeper look at why timing matters so much, see our dedicated guide on the importance of early diagnosis in cerebral palsy.
Knowing which infants carry higher risk shapes how closely to screen them.
Eight factors mark a baby for closer surveillance. Premature birth, especially before 32 weeks, is the single biggest risk factor. Low birth weight, particularly under 3.3 pounds. Birth complications including oxygen deprivation, traumatic delivery and cord problems. Maternal infections such as cytomegalovirus, toxoplasmosis and rubella. NICU stays for serious illness, particularly with respiratory failure. Newborn brain hemorrhage or stroke found on imaging in the first weeks. Severe untreated jaundice, since kernicterus is a recognized cause of dyskinetic cerebral palsy. And a family history of cerebral palsy, neurological disorders or unexplained neonatal seizures.
Babies in any of these categories are typically followed in neurodevelopmental clinics with more intensive screening than routine pediatric care provides.
One of the most important things to understand about CP screening: pediatricians and specialists refer to therapy and additional evaluation based on concerns, not certainty. A child doesn’t need to clearly have CP for screening to be useful. The goal is to catch developmental issues whose diagnosis might still be unfolding. Most children referred for early intervention or specialist evaluation don’t end up with a CP diagnosis. Catching the ones who do, early enough for therapy to help, is what makes the system work.
Failure to perform standardized developmental screening at recommended ages, missed cluster of risk factors, or delays in referring to specialists when concerns arise can lead to delayed CP diagnosis and missed therapy windows. When delays cause measurable harm, families sometimes have legal options to recover the cost of intensified care. Our birth injury lawyers review screening histories alongside delivery records. Request a free case review.
Our nurse advocates can walk through what testing has been done, what might still be appropriate, and connect you with specialists in your area. Get a free, confidential evaluation.
Cerebral palsy screening combines several assessment types: physical and neurological exams (muscle tone, reflexes, posture), standardized developmental tools (Ages and Stages Questionnaires, Bayley Scales), specialized infant assessments (General Movements Assessment, Hammersmith Infant Neurological Examination), brain imaging (MRI, cranial ultrasound), and sometimes genetic testing. No single test diagnoses CP: they work together to build the clinical picture.
Early diagnosis combines vigilant developmental monitoring at well-child visits, standardized screening at recommended ages (9, 18, 24 months), specialized assessments for high-risk infants, and brain imaging when concerns arise. Pediatricians refer to neurology when motor or developmental concerns cluster, and pediatric neurologists make the formal diagnosis. The process typically spans months as the clinical picture clarifies.
Early screening matters because the brain is most plastic in the first three years: therapy started during that window builds motor and cognitive skills more effectively than later therapy. Early screening also opens access to early-intervention services, supports educational planning before academic demands intensify, and gives families time to adjust and access resources before they’re urgently needed.
All children should receive standardized developmental screening at 9, 18, and 24 or 30 months, per AAP guidelines. High-risk infants (preemies, NICU graduates, babies with HIE, complicated deliveries) should be enrolled in specialized neurodevelopmental follow-up clinics from the start. Any infant or child showing motor concerns, missed milestones, or unusual muscle tone should be evaluated promptly regardless of age.
Screening tests catch CP early enough to make therapy maximally effective. They distinguish CP from look-alike conditions, support insurance approvals for therapy, document developmental concerns for school-based services, and can identify treatable conditions previously missed. Screening also gives families clearer information earlier, which reduces uncertainty and supports informed decision-making.
Costs vary widely. Standard developmental screening at well-child visits is usually included in routine pediatric care. Brain MRI typically runs $1,000 to $3,000 before insurance. Genetic testing can range from $500 (chromosomal microarray) to $5,000 (whole-exome sequencing) before insurance. Most insurance plans cover medically indicated tests: pre-authorization is common but coverage is usually approved when criteria are met. Early-intervention services for kids under 3 are typically free or low-cost regardless of family income.
Kelsey is an experienced surgical nurse who works extensively with pediatric patients and families navigating birth injuries and cerebral palsy diagnoses. She is licensed by the Missouri Board of Nursing and operates under the Nurse Licensure Compact, allowing her to practice across compact-member states. As both a mentor and patient advocate, Kelsey focuses on safety, communication, and compassionate care: helping families understand medical procedures, treatment options, and the realities of pediatric conditions.
View Kelsey Pabst, RN's full bio →
Our nurses, patient advocates and legal experts are solely focused on bringing you the latest cerebral palsy information, options for financial assistance and access to community support.
Editorial process →The information on this page is provided for general educational purposes and is not a substitute for professional medical or legal advice, diagnosis, or treatment. Always seek the guidance of a qualified physician or attorney with any questions about a medical condition or legal matter. Read our full disclaimer.
